Specifically, KDM1B, also referred to as lysine-specific demethylase 2 (LSD2), promotes the proliferation of MDA-MB-231 breast cancer cells and induces the expression of pluripotent stem cell markers NANOG and SOX2 [17]. Here, KDM1B is linked to breast carcinoma.